Earnings Results, Acquisitions, Agreements, and Quarterly Dividends - Analyst Notes on Mondelez International, Hillshire Brands, Hormel Foods, ADM and Campbell

NEW YORK, May 27, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Mondelez International, Inc. (NASDAQ: MDLZ), The Hillshire Brands Company (NYSE: HSH), Hormel Foods Corp. (NYSE: HRL), Archer Daniels Midland Company (NYSE: ADM) and Campbell Soup Co. (NYSE: CPB). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2981-100free.

Mondelez International, Inc. Analyst Notes
On May 21, 2014, Mondelez International, Inc. (Mondelez International) reported that its Board of Directors declared a regular quarterly dividend of $0.14 per share of Class A common stock. According to Mondelez International, this dividend is payable on July 14, 2014, to shareholders of record as of June 30, 2014. The full analyst notes on Mondelez International are available to download free of charge at:

http://www.analystsreview.com/2981-MDLZ-27May2014.pdf

The Hillshire Brands Company Analyst Notes
On May 15, 2014, The Hillshire Brands Company (Hillshire Brands) announced that it has completed the acquisition of Van's Natural Foods from Catterton Partners. The deal was first announced on April 21, 2014. According to Hillshire Brands, Van's is a leading better-for-you food brand that delivers great taste, nutrition, simple/clean ingredients and all-family appeal across multiple product lines in frozen breakfast and snack foods. Sean Connolly, President and CEO, Hillshire Brands, stated, "Van's is a proven health and wellness brand that has attracted a loyal consumer following. Adding Van's delicious products and talented team to our organization will expand Hillshire Brands' presence in the frozen category and beyond and help us to drive even greater health and wellness innovation." The full analyst notes on Hillshire Brands are available to download free of charge at:

http://www.analystsreview.com/2981-HSH-27May2014.pdf

Hormel Foods Corp. Analyst Notes
On May 21, 2014, Hormel Foods Corp. (Hormel Foods) reported its financial results for Q2 FY 2014 (period ended April 27, 2014). Net sales increased 4.3% YoY to $2.2 billion. Net earnings attributable to the Company were $140.1 million or $0.52 per diluted share, compared to $125.5 million or $0.46 per diluted share in Q2 FY 2013. Commenting on the outlook, Chairman, President and CEO Jeffrey M. Ettinger stated, "Elevated pork, beef, turkey, and avocado costs, driven by tighter raw material supplies, are presently compressing margins on many of our value-added products. We are maintaining our fiscal 2014 guidance range of $2.17 to $2.27 per share, but expect these cost pressures to push our full year earnings toward the lower end of this range." The full analyst notes on Hormel Foods are available to download free of charge at:

http://www.analystsreview.com/2981-HRL-27May2014.pdf

Archer Daniels Midland Company Analyst Notes
On May 19, 2014, Archer Daniels Midland Company (ADM) announced that the Company and Synthetic Genomics, Inc. have entered into a long-term agreement to commercialize Omega-3 Docosahexaenoic Acid (DHA) from algae. ADM stated that as a part of the agreement between the two companies, Omega-3 DHA will be produced and marketed throughout the world by ADM's Foods & Wellness and Animal Nutrition groups. The full analyst notes on ADM are available to download free of charge at:

http://www.analystsreview.com/2981-ADM-27May2014.pdf

Campbell Soup Co. Analyst Notes
On May 19, 2014, Campbell Soup Co. (Campbell) reported its financial results for Q3 FY 2014 (period ended April 27, 2014). Net sales increased 0.4% YoY to $2 billion. Net earnings attributable to the Company were $184 million or $0.58 per diluted share, compared to net earnings of $181 million or $0.57 per diluted share in Q3 FY 2013. The Company informed that it has revised its FY 2014 guidance. Campbell now expects sales from continuing operations to grow c.3%, down from the previous range of 4-5%, and adjusted EPS to be at the low end of the previously announced guidance of 2-4%, or $2.53 to $2.58 per share, for FY 2014. The full analyst notes on Campbell are available to download free of charge at:

http://www.analystsreview.com/2981-CPB-27May2014.pdf

About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

EDITOR'S NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED